Design for a Lithographically Patterned Bioartificial Endocrine Pancreas

Artificial Organs

Volumn 37, Issue 12, 2013, Pages 1059-1067

  Park, Jaehyun ^a   Kalinin, Yevgeniy V ^a   Kadam, Sachin ^a   Randall, Christina L ^b   Gracias, David H ^a,c  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Bioartificial pancreas; BioMEMS; Cell encapsulation therapy; Diabetes; Insulin; Nanotechnology

Indexed keywords

CELLS; CYTOLOGY; ENCAPSULATION; SELF ASSEMBLY;

BIO-ARTIFICIAL PANCREAS; BIOARTIFICIAL; CELL ENCAPSULATION THERAPY; CELL ENCAPSULATIONS; CELL-BE; CELL/B.E; ENCAPSULATED CELL; PORE CHARACTERISTICS; PORE SPACING; PROOF OF CONCEPT;

INSULIN;

ALGINIC ACID;

ARTICLE; ARTIFICIAL ORGAN; BIOARTIFICIAL ENDOCRINE PANCREAS; CELL ENCAPSULATION; EQUIPMENT DESIGN; MATERIAL COATING; POROSITY; PRIORITY JOURNAL; SIMULATION;

BIOARTIFICIAL PANCREAS; BIOMEMS; CELL ENCAPSULATION THERAPY; DIABETES; INSULIN; NANOTECHNOLOGY;

ANIMALS; BIOARTIFICIAL ORGANS; CELL HYPOXIA; CELL LINE, TUMOR; COMPUTER-AIDED DESIGN; EQUIPMENT DESIGN; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; NANOSTRUCTURES; OXYGEN; POROSITY; SURFACE PROPERTIES; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84890241295     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12131     Document Type: Article

References (55)

1. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001;24:131-153.
2. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years. Diabetes Care 2002;25:593-598.
3. Klonoff DC. Continuous glucose monitoring. Diabetes Care 2005;28:1231-1239.
4. Renard E, Place J, Cantwell M, Chevassus H, Palerm CC. Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery. Diabetes Care 2010;33:121-127.
5. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908-910.
6. Chang TMS. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov 2005;4:221-235.
7. Silva AI, de Matos AN, Brons IG, Mateus M. An overview on the development of a bio-artifcial pancreas as a treatment of insulin-dependent diabetes mellitus. Med Res Rev 2006;26:181-222.
8. Storrs R, Dorian R, King SR, Lakey J, Rilo H. Preclinical development of the islet sheet. Ann N Y Acad Sci 2001;944:252-266.
9. Lembert N, Petersen P, Wesche J, et al. In vitro test of new biomaterials for the development of a bioartificial pancreas. Ann N Y Acad Sci 2001;944:271-276.
10. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991;254:1782-1784.
11. Desai TA, Chu WH, Tu JK, Beattie GM, Hayek A, Ferrari M. Microfabricated immunoisolating biocapsules. Biotechnol Bioeng 1998;57:118-120.
12. Jay SM, Saltzman WM. Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. J Control Release 2009;134:26-34.
13. De Vos P, De Haan B, Pater J, Van Schilfgaarde R. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. Transplantation 1996;62:893-899.
14. Santini JT Jr, Cima MJ, Langer R. A controlled-release microchip. Nature 1999;397:335-338.
15. Leoni L, Desai TA. Micromachined biocapsules for cell-based sensing and delivery. Adv Drug Deliv Rev 2004;56:211-229.
16. Lesinski GB, Sharma S, Varker KA, Sinha P, Ferrari M, Carson WE III. Release of biologically functional interferon-alpha from a nanochannel delivery system. Biomed Microdevices 2005;7:71-79.
17. Gimi B, Kwon J, Liu L, et al. Cell encapsulation and oxygenation in nanoporous microcontainers. Biomed Microdevices 2009;11:1205-1212.
18. Gimi B, Leong T, Gu Z, et al. Self-assembled three dimensional radio frequency (RF) shielded containers for cell encapsulation. Biomed Microdevices 2005;7:341-345.
19. Syms RRA, Yeatman EM, Bright VM, Whitesides GM. Surface tension-powered self-assembly of microstructures-the state-of-the-art. JMEMS 2003;12:387-417.
20. Randall CL, Kalinin YV, Jamal M, Shah A, Gracias DH. Self-folding immunoprotective cell encapsulation devices. Nanomedicine 2011;7:686-689.
21. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radio-therapy. Br J Cancer 1955;9:539-549.
22. Randall CL, Kalinin YV, Jamal M, Manohar T, Gracias DH. Three-dimensional microwell arrays for cell culture. Lab Chip 2011;11:127-131.
23. Smidsrød O, Skjåk-Bræk G. Alginate as immobilization matrix for cells. Trends Biotechnol 1990;8:71-78.
24. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J Control Release 2006;114:1-14.
25. Gin H, Dupuy B, Baquey C, Ducassou D, Aubertin J. Agarose encapsulation of islets of Langerhans: reduced toxicity in vitro. J Microencapsul 1987;4:239-242.
26. Weber LM, He J, Bradley B, Haskins K, Anseth KS. PEG-based hydrogels as an in vitro encapsulation platform for testing controlled β-cell microenvironments. Acta Biomater 2006;2:1-8.
27. George S, Nair PD, Risbud MV. Bhonde RR. Nonporous polyurethane membranes as islet immunoisolation matrices-biocompatibility studies. J Biomater Appl 2002;16:327-340.
28. Fernandes R, Gracias DH. Self-folding polymeric containers for encapsulation and delivery of drugs. Adv Drug Deliv Rev 2012;64:1579-1589.
29. Bridges AW, García AJ. Anti-inflammatory polymeric coatings for implantable biomaterials and devices. J Diabetes Sci Technol 2008;2:984-994.
30. Prakash SB, Abshire P. On-chip capacitance sensing for cell monitoring applications. IEEE Sens J 2007;7:440-447.
31. Ahmadi MM, Jullien GA. A wireless-implantable microsystem for continuous blood glucose monitoring. IEEE Trans Biomed Circuits Syst 2009;3:169-180.
32. Buchwald P. FEM-based oxygen consumption and cell viability models for avascular pancreatic islets. Theor Biol Med Model 2009;6:5.
33. Garofano A, Czernichow P, Bréant B. Beta-cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia 1998;41:1114-1120.
34. Granot Z, Swisa A, Magenheim J, et al. LKB1 regulates pancreatic β cell size, polarity, and function. Cell Metab 2009;10:296-308.
35. Ryan EA, Lakey JRT, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002;51:2148-2157.
36. Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
37. Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994;343:950-951.
38. Rosenberg L. Clinical islet cell transplantation. Are we there yet? Int J Pancreatol 1998;24:145-168.
39. Kobayashi N. Cell therapy for diabetes mellitus. Cell Transplant 2006;15:849-854.
40. Kulkarni RN. The islet β-cell. Int J Biochem Cell Biol 2004;36:365-371.
41. Yamaoka T. Regeneration therapy of pancreatic β cells: towards a cure for diabetes? Biochem Biophys Res Commun 2002;296:1039-1043.
42. Botar CC, Vasile T, Sfrangeu S, et al. Validation of CFD simulation results in case of portal vein blood flow. 20th European Symposium on Computer Aided Process Engineering 2010;28:205-210.
43. Maki T, Ubhi CS, Sanchez-Farpon H, et al. Successful treatment of diabetes with the biohybrid artificial pancreas in dogs. Transplantation 1991;51:43-51.
44. Sullivan SJ, Maki T, Borland KM, et al. Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 1991;252:718-721.
45. Merani S, Toso C, Emamaullee J, Shapiro AMJ. Optimal implantation site for pancreatic islet transplantation. Br J Surg 2008;95:1449-1461.
46. Strauss R. SMT Soldering Handbook, 2nd Edition. Oxford: Newnes, 1998.
47. Waldhäusl WK, Bratusch-Marrain PR, Francesconi M, Nowotny P, Kiss A. Insulin production rate in normal man as an estimate for calibration of continuous intravenous insulin infusion in insulin-dependent diabetic patients. Diabetes Care 1982;5:18-24.
48. Rankin MM, Kushner JA. Adaptive β-cell proliferation is severely restricted with advanced age. Diabetes 2009;58:1365-1372.
49. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26:1079-1087.
50. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-309.
51. Hamann A, Matthaei S, Rosak C, Silvestre L; HOE901/4007 Study Group. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care 2003;26:1738-1744.
52. Chou SY, Krauss PR, Renstrom PJ. Imprint lithography with 25-nanometer resolution. Science 1996;272:85-87.
53. Wang J, Patel M, Gracias DH. Self assembly of three dimensional nanoporous containers. Nano 2009;4:1-5.
54. Desai TA, Hansford DJ, Leoni L, Essenpreis M, Ferrari M. Nanoporous anti-fouling silicon membranes for biosensor applications. Biosens Bioelectron 2000;15:453-462.
55. James T, Kalinin YV, Chan CC, Randhawa JS, Gaevski M, Gracias DH. Voltage-gated ion transport through semiconducting conical nanopores formed by metal nanoparticle assisted plasma etching. Nano Lett 2012;12:3437-3442.